Search research articles
Contact Us
Filters
Showing results (91-100 of 120) with videos related to
Page
of 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
July 10, 2024
Control of G protein-coupled receptor function via membrane-interacting intrinsically disordered C-terminal domains
Chiara D Mancinelli, Dagan C Marx, Alberto J Gonzalez-Hernandez, et al.
The Journal of Biological Chemistry
|
February 22, 2018
Structural basis of sterol binding and transport by a yeast StARkin domain
Julian-Alexander Jentsch, Irene Kiburu, Kalpana Pandey, et al.
Frontiers in Molecular Neuroscience
|
June 10, 2017
Unique Structural Features of Membrane-Bound C-Terminal Domain Motifs Modulate Complexin Inhibitory Function
David Snead, Alex L Lai, Rachel T Wragg, et al.
Frontiers in Molecular Neuroscience
|
June 13, 2017
Evolutionary Divergence of the C-terminal Domain of Complexin Accounts for Functional Disparities between Vertebrate and Invertebrate Complexins
Rachel T Wragg, Daniel A Parisotto, Zhenlong Li, et al.
Journal of the American Chemical Society
|
February 21, 2012
Elucidating the role of C-terminal post-translational modifications using protein semisynthesis strategies: α-synuclein phosphorylation at tyrosine 125
Mirva Hejjaoui, Sara Butterfield, Bruno Fauvet, et al.
ACS Chemical Biology
|
June 30, 2016
Semisynthetic and in Vitro Phosphorylation of Alpha-Synuclein at Y39 Promotes Functional Partly Helical Membrane-Bound States Resembling Those Induced by PD Mutations
Igor Dikiy, Bruno Fauvet, Ana Jovičić, et al.
Biorxiv : the Preprint Server for Biology
|
October 24, 2023
Phosphoglycerate kinase is a central leverage point in Parkinson's Disease driven neuronal metabolic deficits
Alexandros C Kokotos, Aldana M Antoniazzi, Santiago R Unda, et al.
Science Advances
|
August 21, 2024
Phosphoglycerate kinase is a central leverage point in Parkinson's disease-driven neuronal metabolic deficits
Alexandros C Kokotos, Aldana M Antoniazzi, Santiago R Unda, et al.
Human Molecular Genetics
|
April 15, 2014
The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells
Mohamed-Bilal Fares, Nadine Ait-Bouziad, Igor Dikiy, et al.
Cell Reports
|
April 13, 2022
Synaptic vesicle binding of α-synuclein is modulated by β- and γ-synucleins
Kathryn E Carnazza, Lauren E Komer, Ying Xue Xie, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 120) with videos related to
Sort By:
Page
of 12
Proceedings of the National Academy of Sciences of the United States of America
|
July 10, 2024
Control of G protein-coupled receptor function via membrane-interacting intrinsically disordered C-terminal domains
Chiara D Mancinelli, Dagan C Marx, Alberto J Gonzalez-Hernandez, et al.
The Journal of Biological Chemistry
|
February 22, 2018
Structural basis of sterol binding and transport by a yeast StARkin domain
Julian-Alexander Jentsch, Irene Kiburu, Kalpana Pandey, et al.
Frontiers in Molecular Neuroscience
|
June 10, 2017
Unique Structural Features of Membrane-Bound C-Terminal Domain Motifs Modulate Complexin Inhibitory Function
David Snead, Alex L Lai, Rachel T Wragg, et al.
Frontiers in Molecular Neuroscience
|
June 13, 2017
Evolutionary Divergence of the C-terminal Domain of Complexin Accounts for Functional Disparities between Vertebrate and Invertebrate Complexins
Rachel T Wragg, Daniel A Parisotto, Zhenlong Li, et al.
Journal of the American Chemical Society
|
February 21, 2012
Elucidating the role of C-terminal post-translational modifications using protein semisynthesis strategies: α-synuclein phosphorylation at tyrosine 125
Mirva Hejjaoui, Sara Butterfield, Bruno Fauvet, et al.
ACS Chemical Biology
|
June 30, 2016
Semisynthetic and in Vitro Phosphorylation of Alpha-Synuclein at Y39 Promotes Functional Partly Helical Membrane-Bound States Resembling Those Induced by PD Mutations
Igor Dikiy, Bruno Fauvet, Ana Jovičić, et al.
Biorxiv : the Preprint Server for Biology
|
October 24, 2023
Phosphoglycerate kinase is a central leverage point in Parkinson's Disease driven neuronal metabolic deficits
Alexandros C Kokotos, Aldana M Antoniazzi, Santiago R Unda, et al.
Science Advances
|
August 21, 2024
Phosphoglycerate kinase is a central leverage point in Parkinson's disease-driven neuronal metabolic deficits
Alexandros C Kokotos, Aldana M Antoniazzi, Santiago R Unda, et al.
Human Molecular Genetics
|
April 15, 2014
The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells
Mohamed-Bilal Fares, Nadine Ait-Bouziad, Igor Dikiy, et al.
Cell Reports
|
April 13, 2022
Synaptic vesicle binding of α-synuclein is modulated by β- and γ-synucleins
Kathryn E Carnazza, Lauren E Komer, Ying Xue Xie, et al.
Page
of 12